Gene · 1200
Papers2,632
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,632
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Acidified drinking water improves motor function, prevents tremors and changes disease trajectory in Cln2R207X mice, a model of late infantile Batten disease. | Sci Rep | 2023 | 37932327 | PubTator, text mining | PubMed |
| CLN2 disease resulting from a novel homozygous deep intronic splice variant in TPP1 discovered using long-read sequencing. | Mol Genet Metab | 2023 | 37922835 | PubTator, text mining | PubMed |
| Compound heterozygous mutations in tripeptidyl peptidase 1 cause rare autosomal recessive spinocerebellar ataxia type 7: A case report. | World J Clin Cases | 2023 | 37900245 | PubTator, text mining | PubMed |
| Are Proton Pump Inhibitors Contributing in Emerging New Hypertensive Population? | Pharmaceuticals (Basel) | 2023 | 37895858 | PubTator, text mining | PubMed |
| miR-3200 accelerates the growth of liver cancer cells by enhancing Rab7A. | Noncoding RNA Res | 2023 | 37860266 | PubTator, text mining | PubMed |
| Genetic assessment of pathogenic germline alterations in lysosomal genes among Asian patients with pancreatic ductal adenocarcinoma. | J Transl Med | 2023 | 37848935 | PubTator, text mining | PubMed |
| MCCC2 is a novel mediator between mitochondria and telomere and functions as an oncogene in colorectal cancer. | Cell Mol Biol Lett | 2023 | 37828426 | PubTator, text mining | PubMed |
| Catching the Culprit: How Chorea May Signal an Inborn Error of Metabolism. | Tremor Other Hyperkinet Mov (N Y) | 2023 | 37810989 | PubTator, text mining | PubMed |
| Double-strand DNA break repair: molecular mechanisms and therapeutic targets. | MedComm (2020) | 2023 | 37808268 | PubTator, text mining | PubMed |
| Mitochondrial-related genes markers that predict survival in patients with head and neck squamous cell carcinoma affect immunomodulation through hypoxia, glycolysis, and angiogenesis pathways. | Aging (Albany NY) | 2023 | 37796226 | PubTator, text mining | PubMed |
| Premature senescence and cardiovascular disease following cancer treatments: mechanistic insights. | Front Cardiovasc Med | 2023 | 37781317 | PubTator, text mining | PubMed |
| System analysis based on the lysosome-related genes identifies HPS4 as a novel therapy target for liver hepatocellular carcinoma. | Front Oncol | 2023 | 37781184 | PubTator, text mining | PubMed |
| Ginsenoside F1-Mediated Telomere Preservation Delays Cellular Senescence. | Int J Mol Sci | 2023 | 37762556 | PubTator, text mining | PubMed |
| Extracellular Vesicles from Immune Cells: A Biomedical Perspective. | Int J Mol Sci | 2023 | 37762077 | PubTator, text mining | PubMed |
| Inborn Errors of Metabolism with Ataxia: Current and Future Treatment Options. | Cells | 2023 | 37759536 | PubTator, text mining | PubMed |
| Polysome propensity and tunable thresholds in coding sequence length enable differential mRNA stability. | Sci Adv | 2023 | 37756413 | PubTator, text mining | PubMed |
| Dose selection for biological enzyme replacement therapy indicated for inborn errors of metabolism. | Clin Transl Sci | 2023 | 37735717 | PubTator, text mining | PubMed |
| Associations between telomere attrition, genetic variants in telomere maintenance genes, and non-small cell lung cancer risk in the Jammu and Kashmir population of North India. | BMC Cancer | 2023 | 37718447 | PubTator, text mining | PubMed |
| TERRA expression is regulated by the telomere-binding proteins POT-1 and POT-2 in Caenorhabditis elegans. | Nucleic Acids Res | 2023 | 37713629 | PubTator, text mining | PubMed |
| Proteomic Dissection of Exosome Cargo: Progress and Future Perspectives. | Cancers (Basel) | 2023 | 37686568 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1200/papers?page=8